After receiving a COVID-19 vaccine, shoulder accidents are uncommon, however they could happen extra steadily than they do after receiving a flu vaccine, in line with a brand new, large-scale research printed in JAMA Inner Drugs.
Shoulder harm associated to vaccine administration (SIRVA) is a situation that may happen after vaccination within the higher arm (deltoid muscle). SIRVA is outlined as shoulder signs within the vaccination arm that start inside seven days of vaccination, final for a minimum of 30 days, and seem to don’t have any different attainable trigger. SIRVA was added to the Nationwide Vaccine Damage Compensation Program harm desk in 2017.
For the research, researchers from Kaiser Permanente Southern California checked out greater than 1.8 million vaccinations administered to 1.4 million adults from August 2023 via April 2024.
Accidents uncommon with each vaccines
The researchers recognized 110 SIRVA instances following 596,614 COVID vaccinations (0.018%) and 142 instances following 1.2 million influenza vaccinations (0.012%), translating to 1.8 instances per 10,000 COVID vaccinations and 1.15 instances per 10,000 flu vaccinations. After adjusting for confounding elements, the crew discovered that COVID vaccination was related to a 63% greater relative danger of vaccine-related shoulder harm.
Amongst adults 65 years and older, SIRVA incidence was 2.1 instances per 10,000 COVID vaccinations, in contrast with 1.6 per 10,000 high-dose flu vaccinations, however the distinction was not statistically important.
“COVID-19 vaccination was related to roughly 7 further instances per 100,000 vaccinations in contrast with influenza vaccination,” write the researchers. “Amongst adults aged 65 years or older, SIRVA danger didn’t differ considerably between COVID-19 and high-dose influenza vaccination.”
Whereas the situation was seen extra typically after COVID vaccination, be aware the researchers, “SIRVA was not often related to each vaccines.”
Advantages outweigh dangers
The most definitely explanation for SIRVA is inadvertent injection into the shoulder joint or surrounding buildings reasonably than the deltoid-muscle goal, probably triggering irritation and chronic ache. Different potential causes embody direct needle-related trauma, vaccine-specific inflammatory responses, and particular person susceptibility elements.
The research authors warning that almost all research contributors obtained the Pfizer/BioNTech mRNA COVID-19 vaccine, which limits the generalizability of the findings.
This research gives reassurance that SIRVA is uncommon after COVID-19 and influenza vaccination.
Additionally they stress that whereas the research didn’t measure particular features of vaccine administration strategies, adhering to really useful intramuscular injection practices is vital in serving to stop SIRVA—a suggestion which may be particularly related for older adults with age-related anatomic adjustments which will contribute to SIRVA.
However each the researchers and the authors of an accompanying editor’s be aware, Alexander Chaitoff, MD, MPH, of the College of Michigan Medical Faculty, and Mitchell H. Katz, MD, of NYC Well being + Hospitals, emphasize the rarity of shoulder problems relative to the advantages of vaccination.
“This research gives reassurance that SIRVA is uncommon after COVID-19 and influenza vaccination and enduring native problems from both vaccine are probably outweighed by their confirmed advantages,” they write.

